MPI Research, in partnership with INVICRO and 3D Imaging, has initiated construction of its new imaging center at MPI’s global corporate headquarters in Mattawan, MI. The 10,000-sq.-ft. imaging center is scheduled to open in Spring 2014, and provides pharma researchers with access to a cyclotron facility directly connected to a vivarium, permitting drug radiolabeling and in-depth study across a wide variety of animal models.
MPI Research, INVICRO and 3D Imaging have collaborated on more than 100 imaging projects to date. The multimillion-dollar project will leverage INVICRO's molecular imaging informatics team and 3D Imaging's radiopharmaceutical group.
"Thanks to the insights and dedication of our team and our partners at INVICRO and 3D Imaging, this addition will further establish MPI Research as a truly one-of-a-kind research facility and global resource for drug development," said MPI Research chairman, president and chief executive officer William U. Parfet. "It is also an important and highly visible reflection of how our community, our region and the state of Michigan continue to move forward as leaders in the life sciences."
"Only the Imaging Center at MPI Research will offer translational imaging capabilities all under one roof," said Jack Hoppin, Ph.D., co-founder and managing partner of INVICRO. "This will fill a void that is not being addressed anywhere in the world, and most importantly, will speed drug discovery and development programs to market."